{
  "drug_name": "Unfractionated_heparin",
  "url": "https://wikem.org/wiki/Unfractionated_heparin",
  "scraped_at": "2026-01-10T08:04:31.472847",
  "sections": {
    "General": {
      "text": "Type:\nAnticoagulant\nDosage Forms: IV, SC\nCommon Trade Names: Heparin",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Anticoagulant",
          "url": "https://wikem.org/wiki/Anticoagulant"
        }
      ]
    },
    "Adult_Dosing": {
      "text": "",
      "subsections": {
        "Thromboembolism": {
          "text": "Bolus: 80 units/kg IV x 1 (MAX: 5,000 units)\nThen drip: 18 units/kg/h IV (MAX: 1,000 units/h)\nAdjust dose to target aPTT levels based on nomogram",
          "tables": []
        },
        "Acute_Coronary_Syndrome": {
          "text": "Bolus: 50 units/kg IV x 1 (MAX: 5,000 units)\nThen drip: 12 units/kg/h IV (MAX: 1,000 units/h)\nAdjust dose to target aPTT levels based on nomogram",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Thromboembolism": {
      "text": "Bolus: 80 units/kg IV x 1 (MAX: 5,000 units)\nThen drip: 18 units/kg/h IV (MAX: 1,000 units/h)\nAdjust dose to target aPTT levels based on nomogram",
      "subsections": {
        "Acute_Coronary_Syndrome": {
          "text": "Bolus: 50 units/kg IV x 1 (MAX: 5,000 units)\nThen drip: 12 units/kg/h IV (MAX: 1,000 units/h)\nAdjust dose to target aPTT levels based on nomogram",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Acute_Coronary_Syndrome": {
      "text": "Bolus: 50 units/kg IV x 1 (MAX: 5,000 units)\nThen drip: 12 units/kg/h IV (MAX: 1,000 units/h)\nAdjust dose to target aPTT levels based on nomogram",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pediatric_Dosing": {
      "text": "IV infusion\nInitial loading dose 75 units/kg given over 10 minutes\nInitial maintenance dose 20 units/kg/hour and adjest per local policy",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Special_Populations": {
      "text": "Pregnancy Rating\n: C\nLactation risk\n: Infant risk minimal\nRenal Dosing\nNo adjustment\nHepatic Dosing\nNo adjustment",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Pregnancy Rating",
          "url": "https://wikem.org/wiki/Drug_Ratings_in_Pregnancy"
        },
        {
          "text": "Lactation risk",
          "url": "https://wikem.org/wiki/Lactation_risk_categories"
        }
      ]
    },
    "Contraindications": {
      "text": "Allergy to class/drug\n33% of patients develop some form of bleeding complication; 2-6% develop major bleeding\nHIT (Heparin-Induced Thrombocytopenia)",
      "subsections": {
        "Risk_Factors_for_Major_Bleeding_Complication": {
          "text": "Recent surgery or trauma\nRenal failure\nAlcoholism\nMalignancy\nLiver failure\nConcurrent use of warfarin, fibrinolytics, steroids, or antiplatelet drugs",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "HIT (Heparin-Induced Thrombocytopenia)",
          "url": "https://wikem.org/wiki/HIT_(Heparin-Induced_Thrombocytopenia)"
        }
      ]
    },
    "Risk_Factors_for_Major_Bleeding_Complication": {
      "text": "Recent surgery or trauma\nRenal failure\nAlcoholism\nMalignancy\nLiver failure\nConcurrent use of warfarin, fibrinolytics, steroids, or antiplatelet drugs",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Adverse_Reactions": {
      "text": "",
      "subsections": {
        "Serious": {
          "text": "Major bleeding\nThrombocytopenia",
          "tables": []
        },
        "Common": {
          "text": "Injection site reaction\n[1]\nHyperkalemia\nAlopecia\nOsteoporosis",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Serious": {
      "text": "Major bleeding\nThrombocytopenia",
      "subsections": {
        "Common": {
          "text": "Injection site reaction\n[1]\nHyperkalemia\nAlopecia\nOsteoporosis",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Common": {
      "text": "Injection site reaction\n[1]\nHyperkalemia\nAlopecia\nOsteoporosis",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pharmacology": {
      "text": "Half-life: 1.5 hrs\nMetabolism: Hepatic\nExcretion: Urine\nMechanism of Action:\nBinds to and activates antithrombin which in turns inactivates factor Xa and thrombin\nAnticoagulation effect lasts up to 3hr after stopping infusion\nMust give IV (not subq) for acute thromboembolic disease\nUnpredictable anticoagulation effect\nMust monitor with PTT; therapeutic range is 1.5-2.5x normal value",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "See_Also": {
      "text": "Unfractionated heparin reversal\nCoagulopathy (main)\nLow molecular weight heparin",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Unfractionated heparin reversal",
          "url": "https://wikem.org/wiki/Unfractionated_heparin_reversal"
        },
        {
          "text": "Coagulopathy (main)",
          "url": "https://wikem.org/wiki/Coagulopathy_(main)"
        },
        {
          "text": "Low molecular weight heparin",
          "url": "https://wikem.org/wiki/Low_molecular_weight_heparin"
        }
      ]
    }
  }
}